Design of rapid and quantitative biosensors with computational protein design
Active Grant Awarded
- Award ID
- R44GM161195
- Recipient
-
Monod Bio, Inc. UEI LB2HDKKRL463
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $377,260
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 37% complete
- Place of performance
- Seattle, WA 98109, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health, through its National Institute of General Medical Sciences, awarded Monod Bio, Inc. Grant R44GM161195 on August 3, 2026, obligating $377,260 under Biomedical Research and Research Training (CFDA 93.859). The award funds the design of rapid, quantitative biosensors using computational protein design to advance Monod Bio's NovoLISA technology. The source positions NovoLISA against traditional biosensing approaches such as ELISAs, which require 90-270 minutes to produce results, involve complex procedures, and carry cross-reactivity risk from insufficient antibody validation. The period of performance runs from August 3, 2026 through May 31, 2027, and work is performed in Seattle, Washington 98109. Monod Bio operates as the prime recipient, with no subcontractor role reported in recent activity. The federal program supports basic research that builds the foundation for advances in disease diagnosis, treatment, and prevention.
Description
- Abstract
- Monod BIO's fast-track proposal aims to advance the novolisa™ technology, transforming biosensing methods in life sciences research. Traditional biosensing approaches, such as elisas, face significant limitations, including prolonged time-to-results (90-270 minutes), complex procedures, extensive antibody development times, and the risk of cross-reactivity due to insufficient antibody validation. In contrast, monod BIO's novolisa assay offers a rapid (
Quick answers
Who received award R44GM161195?
R44GM161195 was awarded to Monod Bio, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on August 3, 2026.
How much is award R44GM161195 worth?
$377,260 has been obligated on R44GM161195.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award